Real-time enrollment status for this urothelial cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:34 AM UTC
| NCT Number | NCT03547973 |
| Recruiting Status | Recruiting |
| Condition | Urothelial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 827 participants |
| Active Locations | 37 sites in the US |
| Sponsor | Gilead Sciences |
| Last Updated on CT.gov | April 15, 2025 (Apr 15, 2025) |
As of March 2, 2026: Clinical trial NCT03547973 is currently recruiting participants. This clinical trial study for urothelial cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by Gilead Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03547973 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03547973 was last updated Apr 15, 2025 (April 15, 2025). HelloStudys verifies this status automatically.